RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      COVID19는 수혈과 혈액관리에 어떠한 영향을 미치는가? = How Does COVID19 Affect Blood Transfusion and Blood Management?

      한글로보기

      https://www.riss.kr/link?id=A107245655

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      The scientific interest in transfusion medicine as related to COVID19 can be summarized in three important points.
      1) How can we identify asymptomatic COVID19 infected potential blood donors from healthy donors, and if the asymptomatic COVID19 infected person has donated blood and it has been transfused, how will it affect the transfused patient? 2) What affect will COVID19 have on blood establishments and medical institutions that use blood? 3) How will convalescent plasma from recovered COVID-19 patients be collected and then be used for patients in need of it? Since COVID19 has a negative effect on blood transfusion and blood management, well developed lines of communication and cooperation from blood establishments, medical institutions, government agencies, and people are urgently needed to overcome the impact of this negative effect. (Korean J Blood Transfus 2020;31:1-4)
      번역하기

      The scientific interest in transfusion medicine as related to COVID19 can be summarized in three important points. 1) How can we identify asymptomatic COVID19 infected potential blood donors from healthy donors, and if the asymptomatic COVID19 infecte...

      The scientific interest in transfusion medicine as related to COVID19 can be summarized in three important points.
      1) How can we identify asymptomatic COVID19 infected potential blood donors from healthy donors, and if the asymptomatic COVID19 infected person has donated blood and it has been transfused, how will it affect the transfused patient? 2) What affect will COVID19 have on blood establishments and medical institutions that use blood? 3) How will convalescent plasma from recovered COVID-19 patients be collected and then be used for patients in need of it? Since COVID19 has a negative effect on blood transfusion and blood management, well developed lines of communication and cooperation from blood establishments, medical institutions, government agencies, and people are urgently needed to overcome the impact of this negative effect. (Korean J Blood Transfus 2020;31:1-4)

      더보기

      참고문헌 (Reference)

      1 노주혜, "코로나바이러스감염증-19에서의 회복기혈장치료 시 고려사항" 대한수혈학회 31 (31): 67-69, 2020

      2 Chenguang Shen, "Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma" American Medical Association (AMA) 323 (323): 1582-, 2020

      3 World Health Organization, "Novel Coronavirus (2019-nCoV) situation report-1" World Health Organization 2020

      4 World Health Organization, "Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19):interim guidance"

      5 Nature news, "How blood from coronavirus survivors might save lives"

      6 World Health Organization, "Coronavirus disease 2019 (COVID-19) situation report-51" World Health Organization 2020

      7 Le Chang, "Coronavirus Disease 2019: Coronaviruses and Blood Safety" Elsevier BV 34 (34): 75-80, 2020

      8 Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, "Change notification UK National Blood Services No. 13 - 2020"

      9 김명한, "COVID-19과 수혈 혈액" 대한수혈학회 31 (31): 61-66, 2020

      10 World Health Organization, "Advice on the use of masks in the community, during home care, and in health care settings in the context of COVID-19: interim guidance"

      1 노주혜, "코로나바이러스감염증-19에서의 회복기혈장치료 시 고려사항" 대한수혈학회 31 (31): 67-69, 2020

      2 Chenguang Shen, "Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma" American Medical Association (AMA) 323 (323): 1582-, 2020

      3 World Health Organization, "Novel Coronavirus (2019-nCoV) situation report-1" World Health Organization 2020

      4 World Health Organization, "Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19):interim guidance"

      5 Nature news, "How blood from coronavirus survivors might save lives"

      6 World Health Organization, "Coronavirus disease 2019 (COVID-19) situation report-51" World Health Organization 2020

      7 Le Chang, "Coronavirus Disease 2019: Coronaviruses and Blood Safety" Elsevier BV 34 (34): 75-80, 2020

      8 Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, "Change notification UK National Blood Services No. 13 - 2020"

      9 김명한, "COVID-19과 수혈 혈액" 대한수혈학회 31 (31): 61-66, 2020

      10 World Health Organization, "Advice on the use of masks in the community, during home care, and in health care settings in the context of COVID-19: interim guidance"

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2028 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2015-01-01 평가 등재후보학술지 유지 (계속평가) KCI등재후보
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2012-01-01 평가 등재후보 1차 FAIL (기타) KCI등재후보
      2011-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2009-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.19 0.19 0.17
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.18 0.16 0.267 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼